Investigating how Borrelia bacteria secrete important surface proteins
Role of Borrelia Lpt Homologs in Surface Lipoprotein Secretion
This study is looking at how the bacteria that cause Lyme disease send important proteins to their surface, which helps them survive and make you sick, with the hope of finding new ways to treat the disease and help patients feel better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10874563 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms by which Borrelia spirochetes, the bacteria responsible for Lyme disease, secrete surface lipoproteins that are crucial for their survival and virulence. By studying the unique protein secretion systems of these bacteria, researchers aim to uncover how these proteins are transported to the bacterial surface and how they contribute to the disease process. The approach involves analyzing the structure and function of these proteins to identify potential targets for new treatments. Patients may benefit from insights gained that could lead to improved therapies for Lyme disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lyme disease or those experiencing symptoms related to Lyme disease.
Not a fit: Patients with Lyme disease who have already undergone extensive treatment and are not experiencing ongoing symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for Lyme disease by targeting the mechanisms of bacterial protein secretion.
How similar studies have performed: Previous research has shown success in understanding bacterial protein secretion mechanisms, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Zueckert, Wolfram R — University of Kansas Medical Center
- Study coordinator: Zueckert, Wolfram R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.